Increased T regulatory cells and decreased Th1 pro-inflammatory cytokines correlate with culture-positive infection in febrile neutropenia childhood oncology patients

Cytokine

Volumn 53, Issue 3, 2011, Pages 286-288

  Hodge, G ^a   Scott, J ^a   Osborn, M ^b   To, L B ^b   Zola, H ^a   Hodge, S ^b   Revesz, T ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Febrile neutropenia; Infection; T regulatory cells; Th1 cytokines

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; BACTERIAL INFECTION; BLOOD CULTURE; BLOOD SAMPLING; BURKITT LYMPHOMA; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KLEBSIELLA PNEUMONIAE; LYMPHOBLASTOMA; LYMPHOCYTE COUNT; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REGULATORY T LYMPHOCYTE; RHABDOID TUMOR; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS ORALIS; TH1 CELL;

ANTIGENS, CD3; ANTIGENS, CD8; BACTEREMIA; CELLS, CULTURED; CHILD; CYTOKINES; FEVER; FLOW CYTOMETRY; HUMANS; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE COUNT; NEOPLASMS; NEUTROPENIA; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79251606240     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.11.009     Document Type: Article

References (10)

1. Freifeld A., Marchigiani D., Walsh T., Chanock S., Lewis L., Hiemenz J., et al. A double blind comparison of empirical oral and intravenous antibiotic therapy for low risk febrile patients with neutropenia during cancer chemotherapy. N. Engl. J. Med. 1999, 341:305-311.
2. Ammann R.A., Hirt A., Luthy R.A., et al. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia. Paediatr. Infect. Dis. 2004, 23:61-67.
3. Hirotsu T., Akatsuka J. Infectious complications in childhood leukemia. Acta Paediatr. Jpn. 1991, 33:564-572.
4. Klaassen R.J., Goodman T.R., Pham B., Doyle J.J. " Low-risk" prediction rule for paediatric oncology patients presenting with fever and neutropenia. J. Clin. Oncol. 2000, 18(5):1012-1019.
5. Romagnani S. The Th1/Th2 paradigm. Immunol. Today 1997, 18:263-266.
6. Hodge G., Osborn M., Hodge S., Nairn J., Tapp H., Kirby M., et al. Rapid simultaneous measurement of multiple cytokines in childhood oncology patients with febrile neutropenia: increased IL-8 or IL-5 correlates with culture-positive infection. Br. J. Haematol. 2005, 132:247-248.
7. Kehrl J.H.T. Ransforming growth factor-β: an important mediator of immunoregulation. Int. J. Cell Cloning 1991, 9:438-450.
8. Stummvoll G.H., DiPaolo R.J., Huter E.N., Davidson T.S., Glass D., Ward J.M., et al. Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. J. Immunol. 2008, 181:1908-1916.
9. Seddiki N., Satner-Nanan B., Martinson J., Zaunders J., Sasson S., Landay A., et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 2006, 7:1693-1700.
10. Hodge G., Davis S., Hodge S., Rice M., Tapp H., Saxon B., et al. Garlic compounds kill childhood pre-B acute lymphoblastic leukemia cells in vitro without reducing T-cell function: potential therapeutic use in treatment of ALL. Biol. Targets Ther. 2008, 2(1):143-149.